Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Nov 2;23(11):1814-1815.
doi: 10.1093/neuonc/noab179.

An early foray with targeted therapy and inspiring novel approaches to combat adult medulloblastoma

Helen A Shih  1
Affiliations
Editorial

An early foray with targeted therapy and inspiring novel approaches to combat adult medulloblastoma

Helen A Shih. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123(4):465–472. - PMC - PubMed
    1. Northcott PA, Buchhalter I, Morrissy AS, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017;547(7663):311–317. - PMC - PubMed
    1. Frappaz D, Barritault M, Montane L, et al. MEVITEM: a phase I/II of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with sonic hedgehog pathway activation. Neuro Oncol. 2021;23(11):1949–1960. - PMC - PubMed
    1. Kool M, Jones DT, Jäger N, et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell. 2014;25(3):393–405. - PMC - PubMed
    1. Li Y, Song Q, Day BW. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis. Acta Neuropathol Commun. 2019;7(1):123. - PMC - PubMed